Healthcare organisations handle some of the most sensitive confidential information in any sector: patient data, unpublished clinical research, proprietary medical technology, and commercially sensitive NHS partnerships. NDAs in a healthcare context carry the same core obligations as in any commercial deal — but they need additional care around data protection, regulatory disclosure, and the specific confidentiality duties that already apply to healthcare workers at common law and under professional codes.
NDASafe is a document preparation service, not a law firm. Our templates are legally reviewed against applicable UK law at the point of release, but every situation is different. Where significant value, unusual risk or a cross-border element is involved, take independent legal advice before you sign.
Why healthcare NDAs are different
A standard commercial NDA protects confidential information and is governed by contract law. In a healthcare setting, two additional legal frameworks run alongside it.
First, health data is special category data under the Data Protection Act 2018 and UK GDPR. Sharing it under an NDA does not remove the data-processing obligation — the NDA needs to identify the categories of personal data involved and confirm that each party will process it lawfully.
Second, healthcare professionals are bound by an independent common law duty of confidence, reinforced by professional codes from the GMC, NMC, HCPC and GDC. An NDA adds contractual teeth to that existing duty — but it operates alongside it, not in place of it.
Common healthcare NDA scenarios
| Scenario | Information shared | NDA shape |
|---|---|---|
| NHS supplier or technology pilot | Commercial terms, operational data, patient-interaction data | Mutual or one-way (NHS organisation as disclosing party) |
| Clinical trial — sponsor and research site | Protocol, interim safety data, MHRA correspondence, IP | Mutual — both sides disclose |
| Medical device company and contract manufacturer | Design files, UKCA documentation, proprietary specifications | One-way NDA in the device company's favour |
| Private clinic and healthcare IT provider | Patient pathways, software integration specs, clinical data | Mutual NDA |
| Healthcare employer and staff member | Patient data, business plans, competitor intelligence | Employee NDA — with mandatory whistleblowing carve-out |
| Healthcare charity and partner organisation | Research findings, donor data, service design | Mutual or one-way depending on information flow |
NHS supplier and procurement NDAs
NHS procurement processes — including competitive dialogue, framework call-offs, and direct awards — frequently involve disclosures of sensitive commercial and operational information before a contract is in place. A supplier sharing a proprietary technology approach with an NHS trust, or a trust sharing operational data to enable a proof-of-concept, both need a signed NDA before that information changes hands.
The NHS Standard Contract includes confidentiality provisions, but these apply to the executed contract. Pre-contract disclosures are not covered. An NDA bridges the gap between first substantive conversation and contract signature.
Where both parties are sharing sensitive information — as often happens in a technology evaluation or partnership scoping — a mutual NDA reflects that two-way flow and gives both sides protection.
NHS bodies are subject to the Freedom of Information Act 2000. Commercially sensitive information can be withheld under section 43 (commercial interests), but this requires a public-interest test. Marking information as confidential under an NDA supports — but does not guarantee — that exemption. If your commercial information is particularly sensitive, take independent legal advice on how the NDA interacts with any FOI obligation on the NHS counterparty.
Clinical trials and research partnerships
Clinical research generates some of the most commercially valuable confidential information in any industry. A phase II trial protocol, interim safety data, or a novel biomarker assay method has enormous commercial value before publication — and real harm if it leaks to a competitor before the results are protected by patent or publication.
The key parties in a clinical trial — sponsor, contract research organisation (CRO), investigator site (hospital or clinic), and data management provider — each receive different categories of confidential information. A single, well-drafted mutual NDA that covers all disclosures across the trial team is cleaner than a web of bilateral agreements.
- Duration — a clinical trial NDA should run for at least the duration of the study plus five years. Proprietary compound data and regulatory submissions should be protected indefinitely.
- Data protection — pseudonymised patient data shared for clinical purposes is still personal data under UK GDPR. The NDA should address how it is handled.
- Publication rights — research sites often want the ability to publish results. A clinical NDA should address this explicitly — usually by requiring the sponsor's prior written consent or a defined review period before publication.
- Regulatory disclosure — the NDA must expressly permit disclosure to the MHRA, ethics committees, and other competent authorities as required.
Medical devices and IP
Medical device companies share highly sensitive technical information with a range of partners: contract manufacturers receive full design files; distributors may receive clinical evidence reports and labelling specifications; NHS and private hospital procurement teams receive technical file summaries.
For UK-placed medical devices, UKCA marking requires conformity assessment and technical documentation under the Medical Devices Regulations 2002 (as amended). That technical file contains the IP that defines the device — and it must be shared with notified bodies and, in some cases, with NHS procurement evaluators. Each disclosure point needs an NDA.
Where a medical device incorporates software (Software as a Medical Device — SaMD), the NDA needs to cover both the device design and the underlying software IP. The Freelancer NDA is particularly relevant for contract development work on SaMD, as it includes IP assignment provisions.
An NDA creates a contractual obligation of confidence. It does not create a lawful basis for processing special category health data under UK GDPR — that requires a separate basis under Article 9(2). Where an NDA covers disclosures that involve patient-identifiable information, review your data-processing obligations separately and consider whether a data-processing agreement is also required alongside the NDA.
Healthcare employees and NDAs
Clinical and non-clinical healthcare employees are often exposed to commercially sensitive information — business strategy, financial plans, patient cohort data, procurement pipelines. An employee NDA is appropriate for any member of staff with meaningful access to information that would cause harm if disclosed.
In healthcare, the mandatory whistleblowing carve-out in an employee NDA takes on added significance. NHS workers and CQC-registered care workers have statutory protections for raising patient safety concerns with the CQC, NHS England, and professional regulators such as the GMC, NMC and GDC. An NDA that purports to silence these disclosures is void under section 43J of the Employment Rights Act 1996, and attempting to use it that way may attract regulatory sanction.
Since 6 April 2026, the Employment Rights Act 2025 has extended the protected-disclosure regime to sexual harassment — see the whistleblowing guide for the full picture.
NDASafe Mutual, One-Way, Employee and Freelancer NDA templates are all suitable for healthcare settings, each including the mandatory whistleblowing carve-outs. £29 each or £79 for all eight — editable Word, delivered instantly.